Dr. Lisa Fortier
James Law Professor of Large Animal Surgery
Associate Chair for the Department of Clinical Sciences Committee on Research and Graduate Education
Perspectives on One-Health Regenerative Medicine
Sunday, September 8, 6:00 PM – 8:00 PM
In the spirit of one-medicine, I have been fortunate to foster a program built on a cross-species, cross-discipline, and cross-campus approach toward understanding the etiopathogenesis of, and exploring therapies for, osteoarthritis. On a more global scale, as President of the International Cartilage Repair Society, I sought along with the board and general membership to lay the framework to simultaneously address osteoarthritis in humans and animals through collaborations between academic institutions, private practitioners, industry partners, regulatory agencies, and the leadership of professional societies. This presentation will highlight some of the lessons learned during the course of several successes and failures toward achieving a one-medicine approach to osteoarthritis.
Amnion-Derived Products – What Are They and How Do They Work?
Tuesday, September 10, 1:30 PM – 2:00 PM
There are numerous commercial products available in veterinary and human markets that are based in the use of amnion tissues including amnion +/- chorion or umbilical cord sheets and amnion or cord blood derived cells marketed as stem cell products. We have evaluated eleven different products using proteomics, live/dead confocal staining, and flow cytometry to characterize these products. Results suggest that products do not contain stem cells and very low to no growth factors. These products reportedly have clinical advantages, but their mechanism of action remains unclear.